A DNA metabolism test can identify genetic variants that influence hormone metabolism, antioxidant capacity, and bone health – all relevant during menopause. For example, variants in VDR (vitamin D receptor), CYP19A1 (aromatase), or SOD2/CAT (antioxidant enzymes) have been associated with osteoporosis risk, hot flashes, or oxidative stress. However, the evidence is mostly mechanistic or based on association studies; no randomized controlled trials demonstrate that such a test significantly improves menopausal symptoms. Clinical utility is therefore limited, and results should not drive treatment decisions alone. Lifestyle factors (diet, exercise, stress management) and medically supervised hormone therapy have much stronger evidence. A DNA test can serve as an additional piece of the puzzle, not a solution. Beware of exaggerated marketing claims: many providers overstate the predictive power. Consulting a physician or nutrition specialist is recommended.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-180b021456d720dd7ae50310